entity (Fresenius Kabi)
86
Structured Review
Fresenius Kabi
entity
Entity, supplied by Fresenius Kabi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/entity/entity/pm41445310-386-24-7
Average 86 stars, based on 1 article reviews
Entity, supplied by Fresenius Kabi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/entity/entity/pm41445310-386-24-7
Average 86 stars, based on 1 article reviews
entity - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: Development and validation of a method for quantitation of CTx-1 for the assessment of biosimilarity of FKS518, a denosumab biosimilar. Article Snippet: Fresenius Kabi has developed FKS518, a fully human monoclonal antibody biosimilar to denosumab.. The clinical development program included two randomized comparative trials: a PK study in healthy volunteers and a safety and efficacy study in osteoporosis patients.. The demonstration of similarity and equivalence between FKS518 and reference denosumab included the quantitation of the serum biomarker C-terminal cross-linking telopeptide of Type 1 collagen (CTx-1), a well-established marker of bone resorption. |